DS-1205

N/A

Report date: 2022/07/19 14:58:24
NME

Base Information

Drug NameDS-1205
Drug Alias NameDS-1205DS-1205cDS-1205bAB-329
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAXL receptor tyrosine kinase inhibitors
TargetsAXL receptor tyrosine kinase
Therapy Area/IndicationsMetastatic breast cancerCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnHeart Therapeutics Co Ltd
Inactive CompaniesDaiichi Sankyo Co Ltd
Active IndicationsMetastatic breast cancer
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A